Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Merrit Debartolo

Urology Woodstock, IL Medical Doctor

NPI 1427379189 CMS profile 1385814

2000 Lake Ave, Woodstock, IL 60098

Open in the dashboard

General payments

$895

14 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Merrit Debartolo of Woodstock, IL is reported in the CMS Open Payments database as having received $895 across 14 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 30th percentile of Urology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $69 1
2020 General $703 10
2019 General $123 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Merrit Debartolo
  • Urology median
  • Middle half of Urology
  • National median

In program year 2025, general payments to Merrit Debartolo were reported at $0. Among 9,461 Urology profiles paid that year, the median was $629 and the middle half received between $190 and $1,620.

Show as a table
Year Merrit Debartolo Urology median Middle half National median
2019 $123 $480 $147–$1,201 $163
2020 $703 $246 $87–$645 $114
2021 $0 $358 $111–$1,000 $132
2022 $0 $476 $143–$1,263 $149
2023 $69 $560 $168–$1,461 $160
2024 $0 $563 $170–$1,464 $164
2025 $0 $629 $190–$1,620 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Olympus Corporation of the Americas $687 9 payments
  2. Medtronic USA, Inc. $91 1 payment
  3. Boston Scientific Corporation $69 1 payment
  4. NeoTract Inc. $30 2 payments
  5. Novartis Pharmaceuticals Corporation $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Travel and Lodging $552 6 payments
  2. Food and Beverage $343 8 payments
Products named General payments · program years 2019–2023
  1. PK SuperPulse $687 9 payments
  2. ShockPulse - SE $687 9 payments
  3. Olympus Accessories $124 1 payment
  4. INTERSTIM $91 1 payment
  5. Moses 550 D\F\L $69 1 payment
  6. UROLIFT $30 2 payments
  7. ENTRESTO $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 23 drugs

Part D claims

1,444

Median for Urology: 1,053

Drug cost

$198,297

Median for Urology: $101,464

Branded share of claims

25.6%

Median for Urology: 27.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Myrbetriq Mirabegron Brand 148 $133,741
Gemtesa Vibegron Brand 28 $26,659
Tamsulosin Hcl Generic 571 $11,085
Estradiol Generic 76 $5,819
Desmopressin Acetate Generic 21 $3,662
Testosterone Cypionate Generic 55 $2,427
Methenamine Hippurate Generic 32 $2,270
Potassium Citrate Er Potassium Citrate Brand 25 $2,257
Tadalafil Generic 16 $2,139
Finasteride Generic 158 $1,942

The 10 drugs with the highest cost, of 23 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 10,221 Part D prescribers listed as Urology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$75,112

Of which drugs: $2,726

Medicare patients

386

Average age 75

Services billed

18,274

97 women, 289 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 46%
Diabetes 32%
Ischemic heart disease 29%
Chronic kidney disease 25%
Cancer 21%
COPD 20%
Heart failure 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

14 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record